A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

RFK Jr.'s comments about the gene-editing technology raise a question about how he would regulate it as head of HHS.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

NHS officials estimate that around 50 people a year will receive treatment now that it has been approved for use for certain ...

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

The company will use the funding to advance clinical trials for Tune-401, the epigenetic silencing drug for treating chronic ...

The therapy involves taking stem cells out of a patient's bone marrow and editing a gene in the cells in a laboratory and ...

MaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.A novel ...